NCT06273111View on ClinicalTrials.gov

Topical Simvastatin for Treating Infantile Hemangioma

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hemangioma Skin
Interventions
DRUG

5% simvastatin ointment

5% simvastatin ointment will be applied directly on IH lesion twice per day for 24 weeks

Trial Locations (1)

94304

Stanford University, Palo Alto

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Joyce Teng

OTHER

NCT06273111 - Topical Simvastatin for Treating Infantile Hemangioma | Biotech Hunter | Biotech Hunter